Edition:
United States

Cellect Biotechnology Ltd (APOP.OQ)

APOP.OQ on NASDAQ Stock Exchange Capital Market

6.95USD
4:00pm EDT
Change (% chg)

$0.13 (+1.91%)
Prev Close
$6.82
Open
$6.85
Day's High
$6.97
Day's Low
$6.85
Volume
1,072
Avg. Vol
20,065
52-wk High
$13.50
52-wk Low
$6.12

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Dec '17
Jun '17 0.00 -0.042
Mar '17 0.00 -0.137
FY 2016 Dec '16 0.00 -0.021
Sep '16 0.00 -0.071
Jun '16 0.00 -0.039
Mar '16 0.00 -0.049
 
*Note: Units in Millions ofShekel
**Note: Units in Shekel

Consensus Estimates Analysis

No consensus analysis data available.

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 200.91 33.50
P/E High - Last 5 Yrs. -- 289.20 46.07
P/E Low - Last 5 Yrs. -- 96.91 24.95
Beta 2.09 0.75 0.80
Price to Sales (TTM) -- 139.09 7.25
Price to Book (MRQ) 10.56 20.64 5.09
Price to Tangible Book (MRQ) 9.65 25.50 6.62
Price to Cash Flow (TTM) -- 130.26 25.50
% Owned Institutions -- 11.26 2.24

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.53
Dividend Yield - 5 Year Avg -- 0.20 0.75
Dividend 5 Year Growth Rate -- 1.97 3.92
Payout Ratio(TTM) -- 9.05 20.54

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 81.71 8.68
Sales (TTM) vs TTM 1 Yr. Ago -- 96.34 11.19
Sales - 5 Yr. Growth Rate -- 34.26 8.22
EPS (MRQ) vs Qtr. 1 Yr. Ago -- -64.57 22.73
EPS (TTM) vs TTM 1 Yr. Ago -- -- --
EPS - 5 Yr. Growth Rate -- 48.47 10.28
Capital Spending - 5 Yr. Growth Rate 80.20 45.82 10.41

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.61 2.53
Current Ratio (MRQ) 6.97 6.04 3.61
LT Debt to Equity (MRQ) 0.00 23.33 11.39
Total Debt to Equity (MRQ) 0.00 25.72 14.02
Interest Coverage (TTM) -- -190.60 39.28

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 35.01 54.05
Gross Margin - 5 Yr. Avg. -- 55.51 52.18
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -150.51 15.90
Operating Margin (TTM) -- -562.45 4.09
Operating Margin - 5 Yr. Avg. -- -162.33 11.23
Pre-Tax Margin (TTM) -- -534.74 4.81
Pre-Tax Margin - 5 Yr. Avg. -- -168.92 11.54
Net Profit Margin (TTM) -- -524.03 1.42
Net Profit Margin - 5 Yr. Avg. -- -168.92 7.87
Effective Tax Rate (TTM) -- -0.15 30.96
Effective Tax Rate - 5 Yr. Avg. -- 18.29 24.26

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 24,331,705 813,295,447
Net Income/Employee (TTM) -- 1,121,504 95,590,786
Receivable Turnover (TTM) -- 6.53 5.56
Inventory Turnover (TTM) -- 2.32 3.44
Asset Turnover (TTM) 0.00 0.40 0.89

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -87.81 -0.74 10.51
Return on Assets - 5 Yr. Avg. -77.20 0.80 11.54
Return on Investment (TTM) -99.56 -0.75 13.17
Return on Investment - 5 Yr. Avg. -87.94 4.16 14.94
Return on Equity (TTM) -119.24 -2.86 14.98
Return on Equity - 5 Yr. Avg. -96.80 -0.19 16.23
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % -49.97 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cellect Biotechnology Ltd

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.